APOA5 antibody (AA 207-366)
Quick Overview for APOA5 antibody (AA 207-366) (ABIN3015485)
Target
See all APOA5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 207-366
-
Sequence
- QELHRSVAPH APASPARLSR CVQVLSRKLT LKAKALHARI QQNLDQLREE LSRAFAGTGT EEGAGPDPQM LSEEVRQRLQ AFRQDTYLQI AAFTRAIDQE TEEVQQQLAP PPPGHSAFAP EFQQTDSGKV LSKLQARLDD LWEDITHSLH DQGHSHLGDP
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 207-366 of human APOA5 (NP_443200.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
Alternative Name
- APOA5
-
Background
- The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified.,APOA5,APOAV,RAP3,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Lipids,Lipoproteins/Apolipoproteins,APOA5
-
Molecular Weight
- 41 kDa
-
Gene ID
- 116519
-
UniProt
- Q6Q788
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Target
-